Pomegranate for knee osteoarthritis: juice and peel extract are not one treatment
Small pomegranate studies tested juice and peel extract in knee osteoarthritis. See why biomarkers, symptoms, and product forms must remain separate.

Two small trials provide early signals, but juice and peel extract differ and neither proves cartilage repair or a reliable pain benefit.
Two pomegranate studies answer different questions
Pomegranate has a vivid health halo, but a useful knee decision starts with the product in the trial. One human study tested juice and included symptom measures. A newer study tested peel extract and focused on blood biomarkers. Those are not interchangeable interventions or outcomes.
The distinction matters in the store. A juice, powdered fruit, peel capsule, and standardized extract may share a plant name while delivering very different compounds and quantities. The evidence belongs to the preparation actually studied.
The juice trial was small and short
A 2016 interventional study randomized 38 people with knee osteoarthritis to pomegranate juice or a control condition for six weeks. WOMAC total, stiffness, and physical-function scores improved in the juice group, and selected antioxidant and matrix-metalloproteinase measures also changed.
The study offers a promising signal, but 38 participants and six weeks leave substantial uncertainty. A questionnaire improvement does not prove cartilage was protected. A change in MMP-13 is a laboratory finding, not a direct image of structural preservation or fewer future knee replacements.

The peel-extract trial emphasized biomarkers
A 2024 randomized double-blind placebo-controlled study enrolled 60 women with obesity and knee osteoarthritis. Participants received 500 milligrams of pomegranate peel extract twice daily or placebo for eight weeks alongside standard drug therapy. Several inflammatory markers and MMP-1 favored the extract.
The published abstract centers on laboratory measures. Those results cannot be converted into a promised amount of pain relief or easier walking. The participants also represent a specific group, and the tested peel extract cannot stand in for a glass of juice or an unspecified pomegranate blend.
Biomarkers are clues, not patient outcomes
Inflammatory pathways and matrix metalloproteinases help researchers explore osteoarthritis biology. They can show whether an intervention affects a proposed mechanism. Yet a lower marker does not automatically mean a person feels better, moves farther, or avoids structural progression.
Strong evidence would connect a well-characterized product to meaningful pain and function outcomes in larger trials, then examine durability and safety. Structural claims would need appropriate imaging and follow-up. The current studies are early pieces, not a completed chain.

Juice and extract create different tradeoffs
Juice contributes carbohydrates and calories, which may matter in an overall eating plan. Peel extracts concentrate different constituents and may carry their own tolerability and interaction questions. Check serving size, added sugar, extract ratio, standardization, and every other active ingredient.
People taking anticoagulants, blood-pressure medicine, diabetes medicine, or several supplements should ask a pharmacist or clinician about fit. A painful, swollen knee also deserves a clear diagnosis rather than an assumption that every symptom is osteoarthritis.
Treat pomegranate as an evidence-matching exercise
If you enjoy pomegranate juice as food, evaluate it as part of the diet. If considering a supplement, ask whether its plant part and dose resemble either trial. A product that does not disclose those details cannot be matched confidently to the research.
The honest conclusion is encouraging but restrained: small studies justify better trials, not cartilage-repair advertising. Keep exercise, physical therapy, weight management when relevant, and prescribed care at the center. Pomegranate can remain an optional candidate without carrying the whole knee plan.
Define success in terms you can notice
If a clinician agrees to a short trial, decide what would count as useful before starting. Choose a repeated task such as a familiar walk, a flight of stairs, or rising from a chair. Record pain, stiffness, and rescue medicine at the same time of day.
Do not use day-to-day fluctuation as proof of cartilage change. Osteoarthritis symptoms naturally vary, and expectation can influence ratings. A consistent record over several weeks is more informative than one unusually active afternoon. If function is worsening, reassess the diagnosis and core treatment plan instead of increasing an unproven extract.
Keep the same footwear and route when repeating a walking task, because small practical differences can distort the comparison.